Click here to BLOCK YOUR CONTENT SPACE IN OUR NEXT ISSUES |
|
|
Articles |
|
|
Expert's Opinion: Three questions about Prefilled Syringes and Parenteral Contract Manufacturing.
Biopharma businesses have made an indisputable impact on our world over the last two years, resulting in a growing strategic role for CDMOs specializing in aseptic fill-finish for injectables – a domain that shows signs of unwavering strength.
|
|
|
| |
| |
|
|
News |
|
|
|
|
Japan Drug Lobby Asserts Pricing Scheme Driving Drug Crisis.
For the first time in the week starting May 16th, Japan’s three major pharmaceutical trade associations joined forces to call for changes to the government’s drug pricing structure in order to prevent missing out on new drug innovation and expansion.
|
|
|
| |
|
Pfizer Pays $11.6 Billion For Migraine Partner Biohaven
Pfizer is putting its substantial gain from COVID-19 drugs to good use by making deals. The company has decided it wants more, six months after partnering with Biohaven Pharma on a migraine medication.
|
|
|
| |
| |
|
|
|
FDA Approves Much Awaited Diabetic Drug Mounjaro From Lilly.
With high hopes, Eli Lilly’s Mounjaro (tirzepatide) was promoted to the big leagues in the week ending May 14, when the FDA approved the type 2 diabetes and weight-loss medication.
|
|
|
| |
|
Cugene And Proteros Offer Value For AbbVie And AstraZeneca.
Smaller biotech startups with promising technology platforms frequently collaborate with larger biopharma companies.
|
|
|
|
|
|
COVID-19 Updates |
|
|
|
|
In Developing Countries, mRNA Boosters Could Be A Smart Buy.
Because of their inexpensive cost, vaccinations made with inactivated SARS-CoV-2 viruses are widely used in underdeveloped countries.
|
|
|
| |
|
Two Years On, Half of COVID-19 Patients Still Symptomatic.
As per a new study that may be one of the oldest and largest on record to track people with protracted COVID, the vast majority of the people who were hospitalised with COVID-19 early in the outbreak had lingering symptoms even two years after their first infection.
|
|
|
| | |
| |
|
|
|
Boosters For COVID-19 Might Be Far More Crucial Than Before.
The Biden administration estimates that up to 100 million additional individuals could contract COVID-19 in the fall and winter due to diminishing immunity and a coronavirus that appears to become more contagious with every new variant.
|
|
|